Confirms Receipt of Two Director Nominees from Daniel J. ManglessStockholders Are Not Required to Take Action at This TimeCELEBRATION, Fla., ...

Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) will likely be announcing its earnings results before the market opens on ...

Analysts at Roth Capital decreased their FY2029 EPS estimates for shares of Zevra Therapeutics in a report issued on Tuesday, March 11th. Roth Capital analyst J. Aschoff now anticipates that the ...

During the last three months, 5 analysts shared their evaluations of Zevra Therapeutics (NASDAQ:ZVRA), revealing diverse outlooks from bullish to bearish. The table below summarizes their recent ...